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ABSTRACT 
RESCUING AGE-RELATED PROTEOLYSIS DEFICITS WITH METHYLENE BLUE  
by 
Shane Pullins 
University of Wisconsin – Milwaukee, 2017 
Under the Supervision of Professor Fred Helmstetter 
  
 The average lifespan is constantly increasing with the advent of new medical techniques, 
and age-related cognitive decline is becoming a prevalent societal issue. Even during healthy 
aging, humans and rats exhibit progressive deficits in episodic/declarative memory.  In 
laboratory rats, age-related memory impairment can be assessed with trace fear conditioning 
(TFC). Recent research implicates ubiquitin proteasome system-mediated protein degradation in 
the synaptic plasticity supporting memory formation and retrieval. In rats, aging leads to 
decreased basal proteolytic activity in brain structures known to support the acquisition and 
retrieval of trace fear memories, and our preliminary data suggests activity-dependent 
proteasome activity declines in a similar fashion. The proposed experiments sought to rescue 
age-related decreases in plasticity-related protein degradation during memory consolidation via 
proteasome stimulation with the compound methylthioninium chloride (methylene blue [MB]). 
Intraperitoneal post-training MB administration at 1, 4, or 16mg/kg did not improve memory 
performance, chymotrypsin-like, or trypsin-like proteasome activity in young or aged rats in any 
of the four brain structures examined. Additionally, dietary treatment with MB for four months 
did not enhance memory, chymotrypsin-like, or trypsin-like proteasome activity in young or 
aged animals. These results suggest that MB may not be well suited to augment fear learning or 
to upregulate general proteasome activity. Future work should investigate other means of 
proteasome stimulation and subsequent rescue of cognitive decline during aging.  
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INTRODUCTION 
Normal Aging and Memory in Humans 
 Aging is common to all organisms; lifespans are finite, and typically a number of 
biological processes go awry with increasing age. The past century has yielded a remarkable 
increase in life expectancy, and one notable burden of this newfound longevity is a decline in 
cognitive ability (Hedden & Gabrieli, 2004). Senescence-related effects exist on a continuum 
ranging from pathological aging, wherein myriad pathologies including Alzheimer’s and 
Parkinson’s diseases may develop, to successful aging, wherein individuals do not display 
significant age-related deficits in cognitive ability (Rowe & Kahn, 1987). Most individuals 
qualitatively age somewhere between pathological and successful aging, in a pattern termed 
normal cognitive aging (Roberson et al., 2012). Even during normal cognitive aging, mnemonic 
function declines and these impairments often negatively affect societal function, independent 
living, and overall health (Petersen, Smith, Kokmen, Ivnik, & Tangalos, 1992). The proportion 
of the U.S. population aged over 65 years is projected to more than double by the year 2050 and 
one out of five individuals will be classified as aged (Ortman, Velkoff, & Hogan, 2014). With an 
increasing number of aged individuals, and subsequent increased prevalence of cognitive aging, 
our healthcare system will undoubtedly experience severe strain. As such, combatting age-
related cognitive decline is one of the most important issues facing the neuroscientific 
community. 
 Normal aging does not globally affect mnemonic processes, rather, certain types of 
memory are more susceptible to age-related impairments (Drag & Bieliauskas, 2010). Memory 
can be broadly divided into four distinct memory systems including procedural memory, 
semantic memory, working memory, and episodic memory (Tulving, 1987). Procedural memory 
pertains to the acquisition and retention of behavioral skills, and seems to remain largely intact 
during normal aging, although age-related motor and coordination deficits may interfere with 
performance (Smith et al., 2005). Semantic memory, or “knowledge”, involves the learning and 
retention of factual information, and results from the Berlin Longitudinal Study suggest that this 
		2	
form of memory remains intact until ~90 years of age (Singer, Verhaeghen, Ghisletta, 
Lindenberger, & Baltes, 2003). Working memory, or the system that facilitates processing and 
mentally manipulating information over short periods of time, does seem to uniformly decline 
during normal aging (Gilinsky & Judd, 1994; Park et al., 2002). However, the focus of this 
proposal will be on episodic memory, which displays consistent and robust age-related deficits 
(L. Nilsson, Bäckman, & Erngrund, 1997). 
 The episodic memory system is responsible for the encoding of personal experiences and 
the conscious recollection of occurrences passed; as such, use of this memory system is largely 
dependent on contextual and spatial cues for proper recall of a previous episode (Nilsson, 2003; 
Tulving, 1987). Numerous reports suggest a global age-related decline in episodic memory 
performance, even during healthy aging (Craik & Rose, 2012; Koen & Yonelinas, 2014; 
reviewed in Rönnlund, Nyberg, Bäckman, & Nilsson, 2005). Specifically, healthy aging impairs 
episodic associative memory involving verbal, written, and pictorial cues (Cabeza et al., 1997; 
Craik & McDowd, 1987; Daselaar, Fleck, Dobbins, Madden, & Cabeza, 2006; Daselaar, 
Veltman, Rombouts, Raaijmakers, & Jonker, 2003; Monti et al., 1996; Naveh-Benjamin, 2000; 
Naveh-Benjamin, Hussain, Guez, & Bar-On, 2003; Provyn, Sliwinski, & Howard, 2007), and 
these deficits seem to consistently manifest after ~60 years of age. Some of the strongest 
evidence for a decline in spatial episodic memory in humans comes from an experiment in which 
participants of various ages were brought into a science exhibit center and allowed to examine a 
number of displays (Uttl & Graf, 1993). After exploring the center, one component of testing 
involved asking participants to place the various items they saw on a map. Performance on this 
component sharply declined after the 6th decade of life, adding support to the notion that, even in 
normally aging participants, episodic memory performance declines after age 60 (Uttl & Graf, 
1993).  
 Collectively, it seems that normal aging is accompanied by an episodic, associative 
memory deficit wherein individuals have difficulty mentally binding elements or cues together in 
time (Golomb, Peelle, Addis, & Kahana, 2008; Monti et al., 1996) and/or space (Driscoll et al., 
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2003; Newman & Kaszniak, 2000; Uttl & Graf, 1993). Together, these patterns of inability have 
problematic implications, which give impetus for appropriately modeling these forms of memory 
in laboratory animals for investigating and correcting age-related memory decline. 
Animal Models of Memory and Aging 
 Fear conditioning is a powerful tool to model human episodic memory processes in 
nonhuman animals. As typically performed in rodents (which will henceforth be the focus of this 
proposal), this paradigm involves repeated pairings of an innocuous conditioned stimulus (CS) 
with an aversive unconditioned stimulus (UCS - footshock) in order to elicit a measurable fear 
response (e.g. freezing behavior). Following successful training, exposure to either the CS (a 
tone in the case of auditory fear conditioning) or the training context is sufficient to elicit 
freezing behavior in absence of the UCS allowing for an index of associative memory strength 
(Gilmartin & Helmstetter, 2010).  
 Numerous variants of Pavlovian fear conditioning have been characterized. Traditionally, 
in auditory fear conditioning the UCS is presented at the offset of the CS in a form of 
conditioning called “delay” fear conditioning (DFC). This training paradigm can model implicit 
memory in that it depends largely on subcortical structures like the amygdala (AMY) in rats and 
humans, and does not require sustained attention or contingency awareness in humans (Bailey, 
Kim, Sun, Thompson, & Helmstetter, 1999; Clark & Squire, 1998; Knight, Nguyen, & 
Bandettini, 2006). In contrast, when the CS and UCS are separated in time by a stimulus-free 
“trace interval” (TI), in a paradigm deemed trace fear conditioning (TFC), the association 
between them is thought to weaken, as successful training requires a greater number of training 
trials (Beylin et al., 2001; Pavlov, 2010). Importantly, the inclusion of this interval is proposed to 
model explicit or episodic memory, as learning this association recruits additional brain 
structures that are known to support episodic associative memory in humans (Connor & Gould, 
2016). Similar to DFC, successful TFC requires the AMY, but TFC also engages the 
hippocampus (HPC), prefrontal cortex (PFC), anterior cingulate cortex (ACC), and retrosplenial 
cortex (RSC) due to the presumed requirement for sustained attention during the trace interval 
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and contingency awareness (Gilmartin, Miyawaki, Helmstetter, & Diba, 2013; Han et al., 2003; 
Knight, Cheng, Smith, Stein, & Helmstetter, 2004; Kochli, Thompson, Fricke, Postle, & Quinn, 
2015; Kwapis, Jarome, Lee, & Helmstetter, 2015; Kwapis, Jarome, Schiff, & Helmstetter, 2011; 
Quinn, Oommen, Morrison, & Fanselow, 2002; Steenland, Li, & Zhuo, 2012; Weike, Schupp, & 
Hamm, 2007). Finally, associative fear conditioning may also be conducted without the use of 
discrete cues in a paradigm called contextual fear conditioning (CFC), which engages a similar 
set of brain structures as TFC (Cowansage et al., 2014; Einarsson & Nader, 2012; Fanselow, 
1980; Gilmartin & Helmstetter, 2010; Kwapis et al., 2015; Quinn, Loya, Ma, & Fanselow, 2005; 
Zelikowsky, Hersman, Chawla, Barnes, & Fanselow, 2014). These various forms of fear 
conditioning have yielded a greater understanding of normal memory formation and retrieval, 
but importantly, they have also been applied to the problem of age-related deficits in learning 
and memory. 
 The pattern of cognitive decline during healthy aging seems to be conserved across 
species (Erickson & Barnes, 2003). Moreover, this pattern seems to implicate dysfunction within 
brain structures critical to memory that comprise the medial temporal lobe (MTL - Barnes, 
1998). Support for this comes from investigations of memory performance in tasks that are 
known to be MTL-dependent (Driscoll & Sutherland, 2005). Relative to young rats, aged rats 
exhibit deficits when tested on the Morris water maze in the fixed position task (which assesses 
spatial memory), the repeated acquisition task (which assesses spatial working memory), as well 
as in discrimination procedures (Driscoll et al., 2006; Frick, Baxter, Markowska, Olton, & Price, 
1995; Gallagher, Burwell, & Burchinal, 1993). Importantly, these deficits are not due to general 
age-related performance effects, and seem to arise from specific hippocampal dysfunction 
(Driscoll et al., 2006; Gallagher et al., 1993). Similarly, age-related spatial memory impairments 
extend to deficits for contextual memory in CFC procedures, which are also sensitive to 
manipulations of the MTL (Houston, Stevenson, McNaughton, & Barnes, 1999; Moyer & 
Brown, 2006; Oler & Markus, 1998; Stoehr & Wenk, 1995; Ward, Oler, & Markus, 1999). 
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 While aged rats seem to be impaired in navigation and fear conditioning paradigms that 
do not involve discrete cues (i.e. CFC procedures), an interesting dichotomy arises within cued 
auditory fear conditioning.  Following DFC, aged rats display reduced memory for the training 
context, but normal memory for the training tone (Houston et al., 1999; Oler & Markus, 1998; 
Stoehr & Wenk, 1995; Ward et al., 1999). However, in TFC procedures, aged rats exhibit 
deficits to the training context and the training tone (McEchron, Cheng, & Gilmartin, 2004; 
Moyer & Brown, 2006; Villarreal, Dykes, & Barea-Rodriguez, 2004). Moyer and Brown (2006) 
examined this selective deficit in TFC and incorporated a control for differences in inter-stimulus 
interval lengths between the two training procedures. Aged rats were trained in either TFC, 
consisting of a 15s tone and a 30s TI prior to each footshock, or long-DFC, consisting of a 45s 
tone co-terminating with a footshock. They found that aged rats had no difficulty learning about 
the training tone in long-DFC procedures, relative to TFC. Additionally, they performed 
important control experiments to determine that this deficit in TFC was not due to decreased 
shock perception or differences in activity levels between young and aged rats (Moyer & Brown, 
2006). Thus, aged rats display reduced associative memory for the tone and footshock only when 
the two are separated in time, a feature that makes this learning paradigm a good model of 
episodic memory. This finding corroborates the previously mentioned idea that MTL dysfunction 
in humans and rodents leads to deficits in memory processing. 
 The details of age-related MTL dysfunction are complicated but some specific cellular 
processes have been investigated.  Numerous reports indicate a reduction in synaptic plasticity, 
especially within the HPC. One of the principle mechanisms underlying synaptic strengthening 
within the HPC is long-term potentiation (LTP). Hippocampal LTP is reduced with increasing 
age (reviewed in Burke & Barnes, 2006). Two main culprits in age-related aberrant LTP are 
imbalances in calcium homeostasis and N-methyl-D-aspartate receptor (NMDAR) dysfunction 
(reviewed in Foster & Kumar, 2002). Additionally, LTP impairments have been attributed to 
reduced surface expression of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor (AMPAR) subunit GluR1, reduced dendritic αCamKII expression, imbalances in 
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kinase/phosphatase activity, reduced spine density and atuophosphorylated CamKII, and reduced 
levels of CREB and phosphorylated CREB (Almaguer, Estupinan, Frey, & Bergado, 2002; Chen 
et al., 2015; Davis et al., 2000; Jouvenceau & Dutar, 2006; Long et al., 2009; Morris & Gold, 
2012). Driscoll and colleagues (2006) examined the aging hippocampus in female rats crossed 
between F344 and Brown Norway hybrid strains. They found reduced hippocampal volume 
when normalized to intracranial volume and reduced neuron density in aged rats. Additionally, 
they quantified dividing cells with BrdU labeling, immature cells with DCX labeling, and 
cycling cells with Ki67 labeling – there were significant age-related reductions in all 
immunohistochemical analyses. Further, these reductions in cellular division and integrity of 
mitosis, correlated with age-related deficits in performance on Morris water maze tasks 
(described above). While their spectroscopy data examining metabolic health in the HPC 
suggests no age related decline in this particular strain of rat, other investigations using solid 
state high-resolution magic angle spinning nuclear magnetic resonance imaging have shown 
decreases in concentrations of various metabolites in Long Evans rats (Driscoll et al., 2006; 
Paban, Fauvelle, & Alescio-Lautier, 2010). However, it may be the case that metabolic deficits 
arise during periods of increased activity or stress, as would be the case during fear learning and 
subsequent memory retrieval (Galeffi, Shetty, Sadgrove, & Turner, 2015). 
 In conclusion, aged humans and aged rats exhibit memory deficits in tasks known to 
depend on the MTL. In tandem with declines in working memory, complex associative memory 
(episodic in humans, TFC in rats) seems to deteriorate with increasing age. Fear conditioning 
procedures like TFC in rats provide a good model for further investigation of aberrant cellular 
function in normal aging. Much is known about the neural mechanisms of HPC dysfunction with 
increasing age, but an exhaustive examination of age-related effects on cellular processing 
remains incomplete. 
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Protein Degradation and Memory 
 There is currently general agreement about the idea that synaptic plasticity related to 
forming new memories requires altered gene expression and de novo protein synthesis in 
neurons (Chen & Tonegawa, 1997; Helmstetter, Parsons, & Gafford, 2008; Kandel, 2001). More 
recently, attention has shifted to the role of protein degradation through the ubiquitin proteasome 
system (UPS) (Ehlers, 2003; Hegde et al., 1997; Mabb & Ehlers, 2010). Within this system, 
proteins are tagged with ubiquitin polypeptides and are subsequently degraded by the 26S 
proteasome complex, which is comprised of a proteolytic core (20S) and two 19S regulatory 
caps (Hegde, 2010). During periods of synaptic activity calcium influx through NMDARs 
increases CamKII signaling, which directly activates the proteasome by phosphorylating serine 
120 on the RPT6 subunit of the 19S cap (Jarome, Kwapis, Ruenzel, & Helmstetter, 2013). This 
phosphorylation activates the proteasome in an ATP-dependent manner, and allows for the 26S 
complex to deubiquitinate, unfold, and degrade substrates (Jarome & Helmstetter, 2013). 
 Once the proteasome complex is activated, it contributes to synaptic destabilization 
which is critical for the consolidation of new memories and following the retrieval of old ones 
(Lee et al., 2008). Known targets of the UPS that contribute to synaptic destabilization include 
AMPAR-associated scaffolding proteins SHANK and GKAP (Hung, Sung, Brito, & Sheng, 
2010; Lee et al., 2008). Once degraded, calcium permeable AMPARs can be dissociated from 
the post-synaptic density allowing for the insertion of calcium impermeable AMPARs, 
ultimately stabilizing long term potentiation and presumably memories (Henley & Wilkinson, 
2013). 
 UPS-mediated proteolysis is required for the synaptic plasticity contributing to the 
formation of many different types of memories in structures including the AMY, DH, and PFC 
(reviewed in Jarome & Helmstetter, 2013). Within the AMY, fear conditioning leads to increased 
lysine 48 (K48)-linked ubiquitin tagging of SHANK and proteins involved in translational 
control, as well as increased proteasome activity evidenced chymotrypsin and trypsin-like 20S 
activity assays (Jarome et al., 2013; Jarome, Werner, Kwapis, & Helmstetter, 2011). Moreover, 
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post-training inhibition of the proteasome with the compound clasto-Lactacystin ß-lactone (ß-
lac) impairs long-term memory formation in a manner similar to protein synthesis inhibition. The 
upregulation of UPS activity following consolidation occurs following auditory or contextual 
memory retrieval as well (Jarome et al., 2011). Interestingly, while inhibition of protein synthesis 
following memory retrieval (with anisomycin) normally produces amnesia, this effect can be 
rescued via co-inhibition of proteolytic activity – an effect that suggests UPS activity triggers the 
need for protein synthesis and directly regulates the destabilization of memory traces.  
 The UPS-mediated processes in the AMY seem to occur in other brain structures as well. 
Inhibitory avoidance training increases ubiquitination of high molecular weight proteins in the 
hippocampus four hours after training (Lopez-Salon et al., 2001). In line with this, proteasome 
inhibition in the CA1 of DH one hour, four hours, or 7 hours following inhibitory avoidance 
training impairs memory. Additionally, following memory retrieval amnestic effects of 
anisomycin may be mitigated via co-infusion of a proteasome inhibitor, suggesting there are 
conserved mechanisms of plasticity between the AMY and the HPC (Lee et al., 2008). Similar to 
the AMY and HPC, Reis and colleagues (2013) found that UPS involvement in mnemonic 
processes is not limited to subcortical structures, as proteolysis in the PFC is critical for trace 
fear memory formation. Following TFC, the PFC displays increased ubiquitination on a similar 
time scale as that of the AMY (Reis et al., 2013). 
 With regard to contributions of the UPS to the plasticity required for TFC in particular, 
there is only one investigation published to date Reis and colleagues (2013). However, given the 
previously documented role of the AMY and the HPC in TFC, it is likely that UPS-mediated 
degradation contributes TFC in these structures (reviewed in Jarome & Helmstetter, 2014). 
Additionally, pilot data from an experiment wherein ß-lac was infused into the AMY of F344 
rats prior to TFC suggests that amygdalar UPS activity is necessary for learning in the trace 
procedure as well (Figure 1). There was no difference in pre-training freezing between the two 
groups (t=0.436 df=7, p=0.67), and there was a modest, but significant, increase in post-training 
freezing in animals that received ß-lac (t=2.515 df=7, p=0.04; Figure 1a). Proteasome inhibition 
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impaired memory formation as evidenced by a reduction in freezing at retrieval during the 
average of the two CS presentations (t=2.139 df=7, p=0.06), during the average of the two TIs 
(t=3.727 df=7, p<0.01), and during the average of the two ITIs (t=5.391 df=7, p<0.01; Figure 
1b). Thus, it seems that neurons within these brain structures that are critical to TFC undergo 
plastic changes during learning, and these cell-level changes depend on the UPS. 
 
 
Age-related Changes in UPS Activity 
 One of the hallmarks of aging is a loss of proteostasis, or an imbalance in the interplay 
between protein synthesis and protein degradation (López-Otín, Blasco, Partridge, Serrano, & 
Kroemer, 2013; Martinez-Vicente, Sovak, & Cuervo, 2005; Saez & Vilchez, 2014). This 
imbalance, initially reviewed more than 30 years ago, usually tips towards an age-related 
decrease in clearance of damaged, misfolded, or normally short-lived proteins resulting in their 
accumulation (Ding & Zhu, 2015; Löw, 2011; Makrides, 1983). Age-related decreases in basal, 
or homeostatic, proteasome activity have been characterized in a number of bodily tissues 
including adipose, kidney, liver, heart, and lung (Baraibar & Friguet, 2012; Keller, Hanni, & 
Markesbery, 2000). These decreases in basal proteasome activity are not limited to somatic 
tissues; they also manifest in aging areas of the central nervous system including the cerebral 
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cortex, HPC, spinal cord, and cerebellum (Chondrogianni, Sakellari, Lefaki, Papaevgeniou, & 
Gonos, 2014; Chondrogianni et al., 2015; Giannini et al., 2013; Keller et al., 2000). 
 There is much debate regarding whether the activity of 20S or 26S proteasome 
complexes is reduced independently from the capacity for degradation. Some work from 
Giannini and colleagues (2013) suggests that, in Sprague Dawley rats, aged 20S and 26S 
proteasomes may be decreased in their activity when quantified via fluorogenic substrate 
degradation (e.g. chymotrypsin [Suc-LLVY-AMC] or trypsin [Bz-VGR-AMC]), but not when 
tested in a way that measures their capacity in requiring the 19S regulatory cap to deubiquitinate 
and unfold the substrate prior to degradation. However, it should be noted that the authors of that 
study did not sufficiently justify the reduction in aged proteasomal activity they observed when 
using the most commonly used proteasome activity assays in the field, and instead focused on 
the artificial substrate they designed to be more physiologically relevant. One other investigation 
of GFP reporter mice claims no age-related impairment in proteasome function, however the 
authors never directly test proteasome activity and instead quantify UPS-related mRNA and 
protein levels during aging (Cook et al., 2009). It may be the case that regulation of 20S core 
activity, either by means of 19S input or an age-related attenuation of 20S catalytic properties, 
underlies the frequently observed loss of proteostasis with increasing age. Indeed, transgenic 
mice engineered to display global reduced chymotrypsin proteasome activity have reduced life 
spans and develop age-related phenotypes suggesting that an age-related reduction in proteasome 
activity is likely involved in cellular and organismal senescence (Tomaru et al., 2012). 
 While substantial evidence exists for a reduction in homeostatic proteasome activity in 
the central nervous system with increasing age, no studies to date have investigated age-related 
changes in UPS function contributing to the synaptic plasticity underlying learning and memory, 
also known as activity-related UPS activity. If the deficits in basal proteolysis extend into 
activity-dependent proteolysis, then age-related impairments in UPS function could be 
responsible for memory decline during normal aging. In order to directly test this, we trained 
young (3 months) and aged (22 months) F344 rats in TFC and brought them back for a retrieval 
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session the following day. The two age groups showed no differences in freezing during the 
training session either before (t=0.1974 df=18, p=0.84) or after the tone-shock pairings (t=0.1845 
df=18, p=0.85; Figure 2a). At retrieval, however, aged rats showed reduced CS freezing (t=2.678 
df=18, p=0.02), TI freezing (t=9.246 df=18, p<0.01), and ITI freezing (t=6.968 df=18, p<0.01; 
Figure 2b). All rats were sacrificed 90 minutes following TFC retrieval for western blot analysis 
of activity-related UPS function, as this time point has been shown to maximally activate the 
UPS following auditory memory retrieval (Jarome et al., 2011). The amygdala and dorsal 
hippocampus were dissected and crude synaptosomal fractions were obtained from both 
structures as previously described (Jarome et al., 2011). Within the amygdala, western blotting 
revealed decreased levels of phosphorylated RPT6 at Serine 120 (t=2.381 df=17, p=0.02; Figure 
2c), no differences in total RPT6 (t=2.002 df=17, p=0.06; Figure 2d), increased K48-linked 
ubiquitin levels (t=2.305 df=17, p=0.03; Figure 2e), and no differences in total actin (t=1.642 
df=17, p=0.12; Figure 2f). This pattern of decreased UPS activation in aged rats following 
memory retrieval was also present in synapses of the dorsal HPC, where we observed decreased 
phosphorylated RPT6 (t=2.028 df=17, p=0.05; Figure 2g), no differences in total RPT6 
(t=0.0076 df=17, p=0.99; Figure 2h), increased levels of K48-linked ubiquitin (t=2.704 df=17, 
p=0.01; Figure 2i), and no differences in actin (t=1.17 df=17, p=0.25; Figure 2j). These results 
suggest decreased activation of the UPS following memory retrieval, evidenced by decreased 
phosphorylated RPT6 and decreased clearance of K48-linked ubiquitin, accompany the age-
related memory deficit observed in aged rats. Thus, stimulation of this activity-dependent UPS 
activity underlying memory formation and retrieval may serve as a novel and therapeutic way to 
treat cognitive decline in normal aging. 
		12	
 
Methylene Blue and Proteasome Activity Upregulation 
 One potential way of stimulating proteasome activity, and rescuing the aforementioned 
age-related decline, is via methylthioninium chloride or methylene blue (MB), administration 
(Medina, Caccamo, & Oddo, 2011). MB is an FDA-grandfathered tricyclic phenothiazine that 
was first synthesized in 1876 as a textile dye, and has since been used as a redox indicator in 
chemical reactions, a supravital/neuroanatomical stain, and a cancer chemotherapy agent (Peter, 
Hongwan, Kupfer, & Lauterburg, 2000; Wainwright & Crossley, 2002). Additionally, MB is 
effective in treating disorders ranging from methemoglobinemia, urinary tract infections, 
malaria, mental disorders (e.g. schizophrenia), and hypoxic effects on the central nervous system 
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resulting from cardiac arrest (Bruchey & Gonzalez-Lima, 2008; Howland, 2016; Oz, Lorke, 
Hasan, & Petroianu, 2010; Schirmer, Adler, Pickhardt, & Mandelkow, 2011).  
 A large portion of MB’s therapeutic effects can be attributed to its unique auto-oxidizable 
properties conferred by the presence of a thiazine ring system and an imine group (Wainwright 
& Crossley, 2002). The thiazine ring system allows for a high reduction potential in the presence 
of oxygen, while the imine group confers antioxidant properties. Combined, these functional 
groups allow MB to participate in electron cycling without incurring any lasting changes in its 
net reduction (Schirmer et al., 2011). This participation in electron cycling allows MB to aid in 
aerobic respiration, particularly during periods of increased bioenergetic demands, stress, or 
disease (Rojas, Bruchey, & Gonzalez-Lima, 2012). 
 Medina and colleagues (2011) administered MB to 3xTg-AD transgenic mice, which 
develop age-related accumulation of Aß and tau and cognitive decline, for four months in their 
diet. Twenty-five milligrams of MB was mixed with every 100 milligrams of food powder, and 
the mice had access to food ad libitum. Unfortunately, this method lacks specificity in terms of 
dosage, but Rojas and colleagues (2012) calculated an approximate dose of 30mg/kg in this 
experiment. Nonetheless, MB treatment successfully prevented the strain-associated decline in 
performance on the spatial reference version of the Morris water maze task. Additionally, MB 
treatment reduced the accumulation of Aß, but not hyper-phosphorylated tau. While previous 
work suggests MB upregulates mitochondrial function, four months of dietary MB 
administration does not affect mitochondrial function in any way (Bruchey & Gonzalez-Lima, 
2008; Medina et al., 2011). MB treatment did not alter amyloid precursor protein processing 
either, which lead the authors to hypothesize that MB-mediated prevention of Aß accumulation 
must occur after Aß has been produced, directly implicating the UPS in clearance of Aß. 
Interestingly, mice that were administered MB displayed higher levels of trypsin-like and 
chymotrypsin-like, but not caspase-like, 20S proteasome activity in whole brain homogenates 
(Medina et al., 2011). Thus, dietary MB administration significantly upregulates two of the three 
types of proteasome activity that are inherent to the UPS, and could possibly rescue the deficits 
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reported in Figure 2, although the brain structures and cellular compartments in which 
proteasome activity is upregulated remain to be elucidated.  
 While there is only one study to date on MB and proteasome upregulation, a number of 
other investigations have demonstrated a role for MB in enhancing mitochondrial function and 
general memory performance (reviewed in Rojas et al., 2012). Collectively, these studies 
revealed that MB displays hormetic properties wherein very low doses do not affect cellular or 
behavioral processes and high doses actually produce deficits in mitochondrial function and 
behavior. The vast majority of these investigations employed acute intraperitoneal (IP) MB 
administration. The first investigation to document MB-mediated memory enhancement showed 
a 1mg/kg IP injection immediately after inhibitory avoidance conditioning enhances retention of 
the avoidance memory (Martinez, Jensen, & Vasquez, 1978). A number of other studies show 
acute and low (i.e. 1-4mg/kg) doses of MB enhance memory in holeboard spatial search 
appetitive tasks, conditioned fear extinction, object recognition, open field habituation, and 
discrimination learning (Callaway, Riha, Bruchey, Munshi, & Gonzalez-Lima, 2004; Callaway, 
Riha, Wrubel, McCollum, & Gonzalez-Lima, 2002; Gonzalez-Lima & Bruchey, 2004; Riha, 
Bruchey, Echevarria, & Gonzalez-Lima, 2005; Riha, Rojas, & Gonzalez-Lima, 2011; Telch et 
al., 2014; Wrubel, Barrett, Shumake, Johnson, & Gonzalez-Lima, 2007a; Wrubel, Riha, 
Maldonado, McCollum, & Gonzalez-Lima, 2007b). 
 The acute and low dose manipulations that improve memory performance reliably 
upregulate cytochrome oxidase activity, and have contributed to the idea that MB participates in 
electron shuttling within the mitochondria and aids in upregulating the aerobic capacity of active 
neurons (Rojas et al., 2012). Unfortunately, no study to date has investigated the effects of acute, 
low dose MB on UPS function and it is possible that the field may have overlooked an additional 
effector for MBs unique memory enhancing properties. Indeed, there exists substantial interplay 
between the mitochondria and the UPS, wherein the UPS serves as a quality control mechanism 
for mitochondrial health especially in aging and disease (Lehmann, Udasin, & Ciechanover, 
2016; Livnat-Levanon & Glickman, 2011; Ross, Olson, & Coppotelli, 2015). Thus, an 
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interaction between these two organelles when MB is administered at low doses still needs to be 
investigated. 
 
Summary and Aims 
 An age-related decline in episodic memory performance in humans is evident, and this is 
analogous to the decline in TFC performance observed in aged rodents. While the UPS normally 
functions to aid in the formation and consolidation of memory, preliminary data suggests age-
related aberrant UPS processing following memory retrieval. Moreover, preventing UPS activity 
in young rats mimics deficits observed in aged rats in TFC. The compound MB offers a novel 
and potentially therapeutic means to rescue age-related proteasome dysfunction, and 
subsequently abolish age-related impairments in TFC. Thus, the overarching aim of the present 
thesis was to address whether MB administration could improve memory in young rats and 
rescue memory impairments in aged rats via upregulation of activity-related UPS activity. 
Specific aims included determining age-appropriate intraperitoneal dosages of MB for peak 
proteasome activity upregulation and memory enhancement (Aim 1) and to use MB in a more 
translational and chronic dietary approach to enhance memory performance and prevent age-
related cognitive decline (Aim 2). In Aim 1, it was predicted that aged rats would require a 
higher acute dose of MB (4 mg/kg) in order to stimulate UPS activity and rescue age-related 
memory impairments, and that young rats would require a lower dose of MB (1 mg/kg) for 
memory enhancement and UPS upregulation. In Aim 2, it was predicted that chronic dietary 
administration of MB would enhance memory and UPS function in young rats, and that aged rats 
receiving the MB diet would display enhanced memory and UPS function relative to aged rats 
receiving the control diet.  
 
MATERIALS & METHODS   
Subjects. Subjects were 100 male F344 rats obtained from Charles River (Raleigh, NC). Aim 1 
consisted of 64 animals, 32 of them were 3 months old and 32 of them were 22 months old at the 
time of delivery. One aged rat died of natural causes after training but before retrieval, and thus 
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produced no data. Aim 2 consisted of 36 animals, 18 of them were 3 months old and 18 of them 
were 18 months old at the time of delivery. Two aged rats died of natural causes during the four-
month feeding period and thus no data was gathered from them. Animals were housed 
individually in shoebox cages with food and water available ad libitum. The colony room was 
maintained under a 14:10 hour light/dark cycle. The University of Wisconsin-Milwaukee 
Institutional Animal Care and Use Committee approved all procedures prior to commencement 
of experimentation. 
 
Conditioning Apparatus. Fear conditioning occurred in a set of four identical chambers (Context 
A). The floor of Context A was composed of stainless steel rods through which footshocks were 
delivered. Each chamber was illuminated by an overhead incandescent bulb and was connected 
to its own shock generator-scrambler (Coulbourn, Whitehall, PA). Ventilation fans provided 
constant background noise (~60 dB). Chambers in Context A were cleaned with a solution of 5% 
ammonium hydroxide between animals. A second set of chambers (Context B) was used to 
conduct auditory CS testing. Context B differed from Context A in a number of ways, including 
infrared lighting, a solid and opaque textured floor panel, and a different cleaning solution (5% 
acetic acid). 
 
Behavioral Procedures. All animals were handled for three days prior to behavioral 
manipulation. This consisted of transport to the behavior room and gentle restraint in a towel. 
Fear conditioning was conducted in Context A while auditory CS testing was conducted in 
Context B. All animals were trace fear conditioned on day 1 with 10 CS-US pairings. The CS 
was a 10s white noise cue (72 dB) and the UCS was a 1s footshock (0.5 mA). Note: the weaker 
shock used in this paradigm was chosen to be sensitive to behavioral enhancements in freezing 
stemming from MB treatment. The CS and UCS were separated by an empty 30s trace interval, 
and CS-USC pairings were separated by an ITI of six minutes. One day following conditioning, 
rats received underwent a retrieval session consisting of two 15s CS presentations following a 2 
		17	
minute baseline period. The two CS’s were separated by 175 seconds allowing for measurement 
of freezing behavior. 
 
Methylene Blue Administration. In Aim 1, USP-grade MB (Sciencelab.com, Houston, TX) was 
dissolved in 0.9% saline to create two stock concentrations, one at 2mg/ml and one at 10mg/ml. 
Rats were weighed the night before behavioral manipulations/injections and received the 
appropriate volume of MB solution corresponding to dosages of 1, 2, 4, and 16 mg/kg injected 
IP. Control rats in both age groups received a similar amount of saline as rats in other conditions 
(0.5mL) to control for volume of IP injections. In Aim 2, control rat chow was ground into a 
fine powder using a food processor and 2g of sucrose was added per 100g of food powder. The 
experimental rat chow was prepared in a similar manner, except 25mg of USP-grade MB was 
added per 100g of control diet. The control and experimental diets were placed in feeding dishes 
in rat cages and replaced every other day during the four-month feeding period. 
 
Conditional Fear Responses. In all cases, the average percent time spent freezing was calculated 
using the FreezeScan 1.0 software (CleverSys, Reston, VA). In Aim 1, two-way ANOVAs (Dose 
x Age) were used to compare group means within each behavioral epoch analyzed (i.e. baseline, 
CS, TI, ITI). In Aim 2, two-way ANOVAs (Diet x Age) were used to compare group means 
within each behavioral epoch analyzed (i.e. baseline, CS, TI, ITI). In both aims, Dunnett’s 
method was used to perform post-hoc comparisons of each group to the 3-month control group 
(Aim 1-control diet, Aim 2-0mg/kg MB) if the interaction term was significant (p<0.05). 
 
Crude Synaptosomal Membrane Fractionation. Animals were sacrificed with an overdose of 
isoflurane. This occurred 90 minutes following TFC retrieval in all experiments. Brains were 
rapidly removed and flash frozen on dry ice. Using a rat brain matrix (Harvard Apparatus, MA) 
incubated on dry ice, structures of interest were dissected from the brains. Synaptosomal 
membrane fractions were obtained using methods previously described, but with minor 
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alterations (Jarome et al., 2011). Tissue samples were homogenized in TEVP buffer with 320 
mM Sucrose and centrifuged at 1000 x g for 10-minutes at 4°C. The supernatant was collected 
and spun at 10,000 x g for 10-minutes at 4°C. The resulting pellet, containing the synaptosomal 
fraction, was resuspended in phospho-homogenization buffer (50 mM Tris-HCl, 6 mM sodium 
deoxycholate, 150 mM NaCl, 1mM NaF, two mini EDTA-free cOmplete protease inhibitor 
tablets (Roche), 0.1% SDS, 1 mM sodium orthovanadate) and measured using a 660nm protein 
assay (Pierce).  
 
20S Proteasome Activity Assay. Brains were removed, frozen on dry ice, and stored at -80°C 
until use. Following dissection, synaptic fractionation, and protein measurement 10μg of sample 
was diluted in distilled water. Diluted samples were then mixed with reaction buffer (250 mM 
HEPES, pH 7.5, 5 mM EDTA, 0.5% NP-40, 0.01% SDS, 20 mM ATP). The fluorogenic 
peptides LLVY-AMC (Millipore, MA) and Bz-VGR-AMC (Enzo Life Sciences) were added to 
samples to assess chymotrypsin-like and trypsin-like activities of the proteasome complex. 
Reactions were incubated at 37°C for two hours and fluorescence was recorded every five 
minutes in a 96-well microplate reader (Synergy H1; Biotek, VA) at 360nm/460nm. Protein-free 
blanks were used to assess auto-hydrolysis of flourogenic peptides and activity was determined 
via interpolation to an AMC standard curve produced following manufacturer instructions. The 
normalized 20S activity assay data was then analyzed using two-way ANOVAs (Dose x Age in 
Aim 1, and Diet x Age in Aim 2). In both aims, Dunnett’s method was used to perform post-hoc 
comparisons of each group to the 3-month control group (Aim 1-control diet, Aim 2-0mg/kg 
MB) only if the interaction term was significant (p<0.05). 
 
Procedure: Aim 1. Male F344 rats aged 3 and 22 months were administered 0, 1, 2, 4, or 16 
mg/kg of MB IP immediately after TFC. Twenty-four hours later, all rats underwent memory 
retrieval and were sacrificed 90 minutes following the retrieval session. Brains were collected 
and the PFC, AMY, DH, and RSC were dissected. After which, samples underwent 
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synaptosomal fractioning and subsequent trypsin-like and chymotrypsin-like 20S proteasome 
activity assays to measure raw UPS activation resulting from MB treatment and memory 
retrieval. Multiple doses of MB were used in order to determine the optimal MB dose for both 
UPS activation as well as for memory enhancement in acute procedures commonly employed in 
the field. 
 
Procedure: Aim 2. This experiment attempted to recapitulate the findings from Medina and 
colleagues (2011) in order to determine if their effects extend to F344 rats and to determine in 
which brain structures and neuronal compartments proteasome activity is upregulated following 
dietary treatment with methylene blue. Male F344 rats aged 3 and 18 months were administered 
a control diet or a diet consisting of 25mg of MB per 100 grams of food powder for four months. 
After four months, all rats were trained in TFC procedures and underwent memory retrieval 24 
hours after conditioning. Ninety minutes following retrieval, rats were sacrificed and brains were 
collected. The PFC, AMY, DH, and RSC were dissected and samples underwent crude 
synaptosomal fractionation prior to trypsin-like and chymotrypsin-like 20S proteasome activity 
assays. The aim of these procedures was to extend findings previously documented by Medina 
and colleagues, and importantly, to give better resolution into the effects of dietary 
administration of MB on memory performance and proteasome activity upregulation in both 
young and aged rats. 
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RESULTS 
Aim 1 
Behavior 
 
 Rats aged 3 months (n=32) or 22 months (n=31) were split into groups to receive 0, 1, 4, 
or 16mg/kg MB IP immediately following TFC. All groups had eight subjects per group except 
for the 22-month 4mg/kg group, which had seven subjects. All rats were trained in TFC. During 
the baseline epoch of training there was a main effect of age on freezing behavior in that aged 
rats froze significantly higher than young animals (F (1,55)=11.22, p<0.01; Figure 3a-b). 
However, during the last TI of training there were no differences in freezing between young and 
aged rats (F (1,55)=0.156, p=0.69; Figure 3a-b). Thus, both age groups behaved similarly at the 
end of training, and there were no age-related deficits in displaying freezing behavior that could 
obfuscate interpretation of freezing behavior at retrieval. Main effects of dose and interaction 
terms were not examined as IP MB administration occurred post-training. 
		21	
 In order to determine the age- and dose-dependent effects of IP MB administration 
immediately following TFC on subsequent memory performance, all rats underwent memory 
retrieval 24 hours after training. During the baseline epoch of retrieval, there was a main effect of 
age on freezing behavior in that aged rats froze significantly less (F (1, 55)=7.911, p<0.01; 
Figure 3c-d). There was no main effect of dose of MB on freezing behavior (F (3, 55)=0.6376, 
p=0.59; Figure 3c-d), and no interaction between dose and age (F (3, 55)=1.79, p=0.16; Figure 
3c-d). Average freezing during the CS presentations at retrieval was lower in aged animals (F (1, 
55)=9, p<0.01; Figure 3c-d), but there was no effect of MB dose (F (3, 55)=1.834, p=0.15; 
Figure 3c-d) and no interaction (F (3, 55)=0.2098, p=0.89; Figure 3c-d). Additionally, aged rats 
froze significantly less than young rats during the two TIs (F (1, 55)=13.51, p<0.001; Figure 3c-
d), but there was no effect of MB dose (F (3, 55)=0.5744, p=0.63; Figure 3c-d) and no 
interaction (F (3, 55)=0.5402, p=0.66; Figure 3c-d). Finally, freezing during the ITIs of retrieval 
was lower in aged rats regardless of MB dose (F (1, 55)=11.95, p<0.01; Figure 3c-d). However, 
there was no effect of dose on memory performance (F (3, 55)=0.5612, p=0.64; Figure 3c-d) and 
no interaction between age and MB dose (F (3, 55)=0.7813, p=0.51; Figure 3c-d). 
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20S Activity Assays 
 
 In order to determine age- and MB dose-dependent differences in plasticity-associated 
20S activity, tissue was collected 90 minutes post-retrieval. Chymotrypsin-like and trypsin-like 
20S activities were measured in synaptic and cytosolic fractions from the PFC, RSC, DH, and 
AMY (Figures 4 and 5).  
 Chymotrypsin-like activity was not consistently upregulated after memory retrieval in 
response to post-training MB administration (Figure 4). In the synaptic fraction of the PFC there 
was no main effect of MB dose (F (3,55)=0.5944, p=0.62; Figure 4a), age (F (1,55)=0.3783, 
p=0.54; Figure 4a), or interaction between the two (F (3,55)=0.7712, p=0.51; Figure 4a). Aged 
rats displayed less chymotrypsin-like 20S activity in the cytosolic fraction of the PFC (F 
(1,55)=13.77, p<0.001; Figure 4e), but there was no effect of MB dose (F (3,55)=1.631, p=0.19; 
Figure 4e), or an interaction (F (3,55)=1.129, p=0.35; Figure 4e).  
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 In the synaptic fraction of the RSC, there was an age related decrease in chymotrypsin-
like activity (F (1,55)=11.05, p<0.01; Figure 4b), a main effect of dose (F (3,55)=5.9, p<0.01; 
Figure 4b), and an interaction between dose and age (F (3,55)=7.345, p<0.001; Figure 4b). 
Furthermore, 16mg/kg MB seems to maximally upregulate proteasome activity in young animals 
and this group was significantly higher than the 0mg/kg 3-month group (p<0.001). In the 
cytosolic fraction of the RSC, there was an age-related reduction in chymotrypsin-like activity 
independent of dose (F (1,55)=39.68, p<0.0001; Figure 4f). There was no main effect of MB 
dose (F (3,55)=2.729, p=0.052; Figure 4f) and no significant interaction between age and dose (F 
(3,55)=1.918, p=0.14; Figure 4f).   
 Within the DH, MB administration seems to differentially affect chymotrypsin-like 20S 
in the synaptic versus the cytosolic cellular compartments. In the synaptic fraction there was a 
significant interaction between dose and age (F (3,55)=4.142, p=0.01; Figure 4c). It seems that as 
the dose of MB increases, proteasome activity decreases in young animals and increases in aged 
animals, although no follow-comparisons of each group to the 0mg/kg 3-month group were 
significant. Additionally, there were no main effects of age (F (1,55)=0.1292, p=0.72; Figure 4c) 
or dose ((F (3,55)=0.6982, p=0.56; Figure 4c). In contrast, cytosolic chymotrypsin-like activity 
changed in an age- and dose-dependent manner. There was a significant interaction between MB 
dose and age ((F (3,55)=3.918, p=0.01; Figure 4g), and follow up comparisons revealed that, for 
aged animals, as the dose increased chymotrypsin-like activity decreased relative to the 0mg/kg 
3-month group (22 month-0mg/kg, p=0.01; 22-month-1mg/kg, p<0.0001; 22-month-4mg/kg, 
p<0.0001; 22-month-16mg/kg, p<0.0001; Figure 4g). Additionally, there was a main effect of 
age (F (1,55)=130.4, p<0.0001; Figure 4g) and dose (F (3,55)=4.708, p<0.01; Figure 4g), 
although these effects are more difficult to interpret given the significant interaction between 
them.  
 There was a dichotomy in the pattern of 20S activation in the AMY between the synaptic 
and cytosolic fractions. In the synaptic portion of the AMY, there was an age-related decrease in 
20S activity regardless of dose (F (1,55)=7.802, p<0.01; Figure 4d), but no main effect of dose 
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(F (3,55)=0.8212, p=0.49; Figure 4d) or interaction (F (3,55)=0.588, p=0.63; Figure 4d). In 
contrast, 20S activity in the cytosolic fraction was higher in aged animals regardless of MB dose 
((F (1,55)=31.07, p<0.0001; Figure 4h). The main effect of dose approached significance (F 
(3,55)=2.53, p=0.067; Figure 4h) and there was no significant interaction (F (3,55)=0.9417, 
p=0.43; Figure 4h).  
 
 Similar to chymotrypsin-like activity, trypsin-like activity was not consistently 
upregulated following memory retrieval in response to post-training MB administration (Figure 
5). In the synaptic fraction of the PFC, there was no effect of age (F (1,55)=2.32, p=0.13; Figure 
5a), dose (F (3,55)=1.028, p=0.39; Figure 5a), or interaction between them (F (3,55)=0.4575, 
p=0.71; Figure 5a). However, in the cytosolic portion of the PFC, dose significantly influenced 
trypsin-like activity and higher doses of MB produced less 20S activity regardless of age (F 
(3,55)=3.829, p=0.01; Figure 5e). There was no main effect of age (F (1,55)=0.841, p=0.36; 
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Figure 5e), or interaction between dose and age (F (3,55)=0.4821, p=0.70; Figure 5e) on 20S 
activity.  
 MB administration greatly affected trypsin-like proteasome activity in the synaptic 
fraction of the RSC. An interaction between age and MB dose was evident (F (3,55)=7.297, 
p<0.001; Figure 5b), and follow-up comparisons to the 3-month 0mg/kg group revealed that 
16mg/kg MB treatment in 3-month animals significantly upregulates 20S activity (p<0.01; 
Figure 5b), while 1mg/kg MB treatment in 22-month animals significantly upregulates 20S 
activity (p<0.01; Figure 5b). Aside from the interaction, there was a general age related increase 
in trypsin-like activity (F (1,55)=15.02, p<0.001; Figure 5b) and a main effect of MB dose (F 
(3,55)=3.406, p=0.04; Figure 5b). In the cytosolic portion of the RSC, there was only an age-
related reduction in 20S activity that was independent of MB dose (F (1,55)=47.15, p<0.0001; 
Figure 5f), and there was no significant effect of MB dose alone (F (3,55)=1.26, p=0.30; Figure 
5f) or an interaction (F (3,55)=1.928, p=0.14; Figure 5f). 
 Much like chymotrypsin-like activity, a similar pattern of trypsin-like activity emerged in 
the DH following MB administration. There were no significant main effects in the synaptic 
fraction (age: F (1,55)=1.353, p=0.25; Figure 5c; dose: F (3,55)=1.34, p=0.27; Figure 5c), or an 
interaction between them (F (3,55)=2.593, p=0.06; Figure 5c). In contrast, data from the 
cytosolic fraction of the DH indicate an age-related reduction (F (1,55)=177.8, p<0.0001; Figure 
5g), and dose-related reduction (F (3,55)=7.378, p<0.001; Figure 5g) in trypsin-like 20S activity. 
However, because the interaction term was not significant (F (3,55)=2.494, p=0.07; Figure 5g), 
follow-up tests were not possible. Nonetheless, it appears that as dose increases, proteasome 
activity in the cytosolic fraction of the DH decreases.  
 Finally, the pattern of trypsin-like proteasome activity in the AMY was the opposite of 
that observed for chymotrypsin-like activity. In the synaptic fraction there was a general age-
related increase in 20S activity (F (1,55)=84.71, p<0.0001; Figure 5d), but no effect of dose (F 
(3,55)=0.8653, p=0.46; Figure 5d) or interaction (F (3,55)=0.3271, p=0.81; Figure 5d). In stark 
contrast, the cytosolic fraction showed an age-related decrease in 20S activity that was 
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independent of MB dose (F (1,55)=57, p<0.0001; Figure 5h). However, dose alone (F 
(3,55)=2.536, p=0.07; Figure 5h) or an interaction between age and dose (F (3,55)=0.2416, 
p=0.87; Figure 5h) did not affect trypsin-like activity in the cytosolic fraction of the DH.  
 
Aim 2 
Behavior 
 
 Rats aged 3 months (n=18) or 18 months (n=18) were split into groups to receive either a 
control diet or an MB-containing diet for a four-month period. All groups had nine subjects per 
group except for the 22-month MB group, which had seven subjects. In order to examine the 
mnemonic effects of dietary treatment with MB on young and aged rats and to extend the 
findings from Medina and colleagues (2011), all rats were trained in TFC at the end of the 4-
month feeding period. During the baseline epoch of training, there were no effects of age (F 
(1,30)=3.681, p=0.06; Figure 6a), diet (F (1,30)=0.0396, p=0.84; Figure 6a), and no age by diet 
interaction (F (1,30)=0.0005, p=0.98; Figure 6a). Importantly, there were also no differences 
between groups in freezing during the last TI of training as a function of age (F (1,30)=1.477, 
p=0.23; Figure 6a), diet (F (1,30)=0.0475, p=0.82; Figure 6a), or an interaction between the two 
(F (1,30)=0.6396, p=0.43; Figure 6a). Thus, it can be concluded that there were no differences in 
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acquisition of freezing behavior between age groups or diet condition during training that may 
confound freezing behavior analysis at retrieval.  
 All rats underwent memory retrieval 24 hours post training in order to examine the 
effects of dietary MB administration on learning and memory processes. During the baseline 
period of retrieval there was no main effect of age (F (1,30)=0.2518, p=0.62; Figure 6b), diet (F 
(1,30)=0.0191, p=0.89; Figure 6b), or an interaction (F (1,30)=1.696, p=0.20; Figure 6b) on 
freezing behavior. Similarly, freezing behavior averaged across the two CS presentations did not 
differ as a function of age (F (1,30)=0.0103, p=0.92; Figure 6b), diet (F (1,30)=2.771, p=0.11; 
Figure 6b), or an interaction between the two (F (1,30)=2.471, p=0.13; Figure 6b). However, 
average freezing during the two TIs was lower in aged animals regardless of diet (F 
(1,30)=7.117, p=0.01; Figure 6b). Diet type did not influence TI freezing (F (1,30)=2.49, p=0.13; 
Figure 6b) and there was no significant interaction between age and diet (F (1,30)=0.8256, 
p=0.37; Figure 6b). ITI freezing was also lower in aged rats regardless of diet type (F 
(1,30)=13.85, p<0.001; Figure 6b), but there was no effect of diet independent of age (F 
(1,30)=2.764, p=0.11; Figure 6b) or significant interaction (F (1,30)=0.2739, p=0.60; Figure 6b).  
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20S Activity Assays 
 
 In order to examine the effects of four months of dietary MB administration on plasticity-
associated 20S proteasome activity in young and aged rats, brain tissue was collected 90 minutes 
post-retrieval. Chymotrypsin-like and trypsin-like 20S activities were measured in synaptic and 
cytosolic fractions from the PFC, RSC, DH, and AMY (Figures 7 and 8).  
 In a manner much similar to IP MB administration in Aim 1, dietary administration of 
MB did not consistently upregulate 20S proteasome activity throughout the brain regions and 
cellular compartments investigated. Dietary treatment with MB significantly upregulated 
chymotrypsin-like activity in the synaptic fraction of the PFC (F (1,30)=5.111, p=0.03; Figure 
7a), but there was no main effect of age (F (1,30)=0.0797, p=0.78; Figure 7a) or an interaction 
between the two (F (1,30)=0.106, p=0.75; Figure 7a). In contrast, the cytosolic fraction of the 
PFC showed an interaction effect between diet and age on chymotrypsin-like activity (F 
(1,30)=6.834, p=0.014; Figure 7e), and follow up tests revealed that MB treatment in young 
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animals significantly reduces 20S activity (p<0.01; Figure 7e). Additionally, there were main 
effects of age (F (1,30)=4.697, p=0.04; Figure 7e) and diet (F (1,30)=7.821, p<0.01; Figure 7e), 
but these are likely driven by the sharp decrease in proteasome activity in young animals that 
received the MB-containing diet.  
 The pattern of chymotrypsin-like 20S activity in the RSC was different between the 
synaptic and cytosolic fractions. Animals that received the MB-containing diet showed higher 
chymotrypsin-like activity in the synaptic fraction of the RSC regardless of age (F (1,30)=34.47, 
p<0.0001; Figure 7b). There was, however, no age-related change in activity (F (1,30)=0.2983, 
p=0.59; Figure 7b) or interaction between age and diet (F (1,30)=1.161, p=0.29; Figure 7b). In 
the cytosolic fraction of the RSC there was an interaction between the effects of age and diet on 
chymotrypsin like activity (F (1,30)=8.293, p<0.01; Figure 7f), and follow up tests showed a 
significant reduction in the 22-month MB group relative to the 3-month control group (p<0.01; 
Figure7f). There was no main effect of age (F (1,30)=0.1761, p=0.68; Figure 7f), but there was a 
main effect of diet (F (1,30)=17.94, p<0.001; Figure 7f) that was likely driven by the sharp 
decrease in proteasome activity in the MB treated aged animals.  
 Dietary treatment with MB did not affect chymotrypsin-like 20S activity in the synaptic 
fraction of the DH. There was no main effect of diet (F (1,30)=1.301, p=0.26; Figure 7c), age (F 
(1,30)=1.665, p=0.21; Figure 7c), or an interaction between them (F (1,30)=0.0045, p=0.95; 
Figure 7c). In contrast, MB treatment significantly increased proteasome activity in the cytosolic 
fraction of the DH regardless of age (F (1,30)=17.08, p<0.001; Figure 7g). There was no main 
effect of age on 20S activity (F (1,30)=0.0273, p=0.87; Figure 7g), but there was an interaction 
between diet and age (F (1,30)=4.82, p=0.04; Figure 7g). Dunnett’s follow up comparisons to the 
3-month MB group showed significant increases in the 3-month MB group (p<0.001; Figure 7g) 
and the 22-month MB group (p=0.02; Figure 7g).  
 Tissue from the AMY, regardless of the cellular compartment, did not show any age-
related or diet-related changes in chymotrypsin-like activity. In the synaptic fraction there was no 
effect of diet (F (1,30)=1.836, p=0.19; Figure 7d), age (F (1,30)=2.939, p=0.10; Figure 7d), or 
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age by diet interaction (F (1,30)<0.0001, p=0.99; Figure 7d). Similarly, in the cytosolic fraction 
of the AMY there was no main effect of diet (F (1,30)=1.095, p=0.30; Figure 7h), age (F 
(1,30)=0.4088, p=0.53; Figure 7h), or interaction between them (F (1,30)=2.216, p=0.15; Figure 
7h) on chymotrypsin-like 20S activity.  
 
 
 Similar to chymotrypsin-like activity, trypsin-like activity was not consistently 
upregulated following memory retrieval in response to four months of dietary MB administration 
(Figure 8). In the synaptic fraction of the PFC, there was no effect of diet (F (1,30)=0.0154, 
p=0.90; Figure 8a), age (F (1,30)=1.194, p=0.28; Figure 8a), or an interaction between them (F 
(1,30)=0.1148, p=0.74; Figure 8a) on 20S activity. In contrast, tissue from the cytosolic fraction 
of the PFC showed MB diet-related increases in trypsin-like activity (F (1,30)=7.778, p<0.01; 
Figure 8e). Age did not significantly affect 20S activity (F (1,30)=0.0584, p=0.81; Figure 8e), 
and there was not an interaction between diet and age (F (1,30)=0.1978, p=0.66; Figure 8e).  
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 Patterns in trypsin-like 20S activity were not consistent between the synaptic and 
cytosolic cellular compartments of the RSC. In the synaptic fraction dietary MB significantly 
upregulated proteasome activity (F (1,30)=11.43, p<0.01; Figure 8b), while age (F 
(1,30)=0.5833, p=0.45; Figure 8b), or an interaction between age and diet (F (1,30)=1.531, 
p=0.23; Figure 8b) did not. Tissue from the cytosolic fraction of the RSC showed clear age-
related decreases (F (1,30)=8.622, p<0.01; Figure 8f) that were independent of dietary treatment 
(F (1,30)=0.1516, p=0.70; Figure 8f) or an age by diet interaction (F (1,30)=3.177, p=0.08; 
Figure 8f).  
 Dietary treatment with MB has opposite effects on trypsin-like proteasome activity in the 
synaptic and cytosolic fractions of the DH. In the synaptic fraction, MB treatment produced a 
modest reduction in 20S activity that did not quite reach significance (F (1,30)=3.806, p=0.06; 
Figure 8c). However, age (F (1,30)=0.0054, p=0.94; Figure 8c) or an interaction between diet 
and age (F (1,30)=0.3884, p=0.54; Figure 8c) had no significant effect on proteolysis. In an 
opposite pattern, MB treatment increased proteolysis in the cytosolic fraction of the RSC (F 
(1,30)=9.702, p<0.01; Figure 8g). There were no significant effects of age (F (1,30)=1.67, 
p=0.21; Figure 8g) or a Diet x Age interaction (F (1,30)=0.1705, p=0.68; Figure 8g).  
 In the synaptic fraction of tissue from the AMY, dietary MB treatment significantly 
reduced trypsin-like 20S activity (F (1,30)=17.41, p<0.001; Figure 8d). Additionally, there was 
an age-related reduction in proteolysis regardless of diet type (F (1,30)=15.2, p<0.001; Figure 
8d), but there was no interaction between dietary and age-related effects (F (1,30)=0.0041, 
p=0.94; Figure 8d). Contrastingly, the MB-containing diet had no effect on 20S activity in 
cytosolic 20S activity in the AMY (F (1,30)=0.0005, p=0.99; Figure 8h). There was, however, an 
age-related reduction in trypsin-like activity that was independent of diet type (F (1,30)=11.79, 
p<0.01; Figure 8d), but the interaction term was not significant (F (1,30)=1.532, p=0.23; Figure 
8d).  
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DISCUSSION 
 Acute MB administration immediately post-training at doses of 1, 4, or 16mg/kg had no 
effect on subsequent memory performance at retrieval in young or aged rats. There was no clear 
MB effect in any of the analyzed epochs, which was unexpected given that we administered 
doses of MB that extended throughout its hormetic curve (Rojas et al., 2012). Our lack of an 
enhancement in young animals given 1mg/kg IP is in contrast to previously published memory 
enhancements with 1mg/kg of MB given IP to adult rats immediately post-inhibitory avoidance 
training (Martinez et al., 1978). Additionally, MB doses above 10mg/kg are known to exert 
deleterious effects on memory performance (for review see Rojas et al., 2012). However, we did 
not see decreased freezing in young or aged animals that received 16mg/kg. The lack of memory 
enhancement or impairment cannot be attributed to general performance deficits between groups, 
as all groups behaved similarly at the beginning and end of training (i.e. all rats displayed 
elevated freezing behavior over time). It is possible that memory enhancing effects of MB do not 
extend to TFC procedures, and may not extend to fear conditioning in general (Rojas et al., 
2012). It is true that no study to date has reported MB-driven enhancement of classical auditory 
fear conditioning, and the majority of MB enhancements are in fear extinction retention, 
decreased fear renewal after extinction, better performance in spatial tasks, or better performance 
in object recognition tasks (Rojas et al., 2012).  
 Although there were no effects of acute MB administration on freezing behavior during 
retrieval in either age group, we did replicate our preliminary finding of an age-related deficit in 
TFC. Aged rats froze significantly less than young rats during all analyzed epochs of retrieval, 
and these results are congruent with previously published age-related deficits in TFC (Moyer & 
Brown, 2006; Villarreal et al., 2004).  
 The lack of a behavioral enhancement with IP MB administration makes the 
interpretation of post-retrieval 20S activity less meaningful. However, there were a few patterns 
of MB-driven upregulation of 20S activity that were conserved between the types of proteasome 
activity examined. Together, it appears the most consistent effects of post-training IP MB 
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administration on proteasome activity measured post-retrieval are in the synaptic fraction of the 
RSC and the cytosolic fraction of the DH. In synapses of the RSC, 16mg/kg seems to 
consistently upregulate general 20S (i.e. chymotrypsin- and trypsin-like) activity in young 
animals, whereas 1mg/kg upregulates general proteasome activity in aged animals. In the 
cytosolic fraction of the DH, general 20S activity is lower in aged animals and MB treatment 
lowers this activity linearly with increasing dose. Apart from these two clear patterns, data from 
the PFC and AMY do not show any consistencies between the types of proteasome activity 
examined.  
 Similar to results with acute MB administration, we did not see any memory 
enhancement with chronic MB administration. There were no age-related or diet-related 
differences in freezing behavior at the beginning or end of training that could have complicated 
our interpretation of freezing behavior at retrieval. During retrieval, the only group differences 
were age-related reductions in average freezing behavior during the TI and ITI periods. While it 
is important that the age-related deficit in TFC was reproduced once again, it is unfortunate that 
MB did not enhance memory performance as reported by Medina and colleagues (2011). There 
are few potential sources for our lack of replication. There were discrepancies in the type of 
memory task used; they saw enhancements in performance on the spatial references version of 
the Morris Water Maze, whereas we were seeking enhancements in fear conditioning. As 
previously mentioned, no study to date has demonstrated an MB-related enhancement in auditory 
fear conditioning and it’s possible that fear conditioning procedures are too robust to observe an 
enhancement. It is also possible that enhancements they observed were species and strain 
specific; they used 3xTg-AD transgenic mice, whereas we used inbred F344 rats (Medina et al., 
2011). Future work should examine if dietary treatment with MB, at the dose of 25mg per 100 
grams of food powder, for four months can enhance spatial memory in non-transgenic rats in 
order to situate our results and extend their findings.  
 The lack of dietary MB-driven memory enhancement makes interpreting post-retrieval 
proteasome activity more difficult. We did not replicate the previously published global 
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upregulation in 20S activity in animals that received the MB-containing diet (Medina et al., 
2011). They measured 20S activity in whole brain homogenates, whereas we had structural and 
cellular compartmental resolution. It is possible that by isolating certain brain structures, we may 
have overlooked other brain regions that drove their observed global increase. However, chronic 
MB administration did increase 20S activity in the synaptic fraction of RSC, much similar to 
acute MB administration. MB also increased 20S activity in the cytosolic fraction of DH when 
administered chronically, which opposed the reductions in 20S activity observed with acute MB 
administration. Nonetheless, given that learning during TFC procedures is dependent on the RSC 
and DH, it is unclear why upregulating proteasome activity in these structures did not enhance 
memory (Kwapis et al., 2015; McEchron, Bouwmeester, Tseng, Weiss, & Disterhoft, 1998). 
While there is evidence for proteasome activity in the DH being involved in CFC, no studies to 
date have investigated the role of the UPS in either the RSC or the DH during TFC (Lee et al., 
2008). Though unlikely, it is possible that these structures do not depend on UPS function in 
TFC procedures.  
 Another possibility is proteasome upregulation does not necessarily correlate with better 
learning, and that previously documented memory enhancements with MB were attributable to 
enhanced mitochondrial function (Rojas et al., 2012). If this were true, MB should have affected 
electron transport in mitochondria, and resulted in some measurable change in behavior. By 
administering MB acutely at doses that cover the hormetic curve, and chronically at a ~30mg/kg 
dose known to be harmful to mitochondria, we should have either positively or negatively 
impacted cellular respiration. The lack of any change in behavior, positive or negative, suggests 
that the changes caused by MB (whether they be on proteolysis or cellular respiration) do not 
affect learning and memory processes in TFC.  
 Given that we have a clear age-related reduction in UPS activity following trace fear 
memory retrieval (Figure 2), work towards stimulating UPS activity should continue. Our results 
suggest that MB may not be well suited for rescue of age-related cognitive decline via 
proteasome activity upregulation. Another promising option for upregulating proteasome activity 
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is proteasome-activating peptide 1 (PAP1). PAP1 incubation in cell cultures from C. elegans and 
H. sapiens increases chymotrypsin-like proteasome activity (Vechio, Cerqueira, Augusto, Lopes, 
& Demasi, 2014).  Additionally PAP1 confers resistance to oxidative stress, and attenuates 
protein accumulation in a cellular model of amyotrophic lateral sclerosis (Vechio et al., 2014). 
PAP1 could be locally infused into structures critical for TFC and could counteract the age-
related decline in UPS function, ultimately rescuing age-related cognitive decline. Nonetheless, 
findings reported here rule out MB as a promising option and allow for advancement of the field 
towards more promising therapeutic options.  
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Pullins,	S.E.,	Pierson,	J.L.,	Burton,	J.M.,	Quinn,	J.J.	2012.	Immunohistochemical	analysis	of	the	dorsal	hippocampus	during	recent	and	remote	fear	memory	retrieval.	The	Society	for	Neuroscience	Annual	Meeting,	New	Orleans.		Pierson,	J.L.,	Pullins,	S.E.,	Quinn,	J.J.	2012.	Expression	of	trace	fear	conditioning	requires	the	dentate	gyrus,	but	not	CA1	or	CA3,	of	the	dorsal	hippocampus.	The	Society	for	Neuroscience	Annual	Meeting,	New	Orleans.			
ORAL	PRESENTATIONS	AND	INVITED	TALKS:		
Pullins,	S.E.,	Cullen,	P.K.,	Helmstetter,	F.J.	2017.	Contributions	of	the	retrosplenial	cortex	to	event-related	and	contextual	memory	formation.	Invited	symposium	speaker	at	the	Midwestern	Psychological	Association	Meeting,	Chicago,	Illinois.	
	
Pullins,	S.E.,	Cullen,	P.K.,	Helmstetter,	F.J.	2017.	Contributions	of	the	retrosplenial	cortex	to	event-related	and	contextual	memory	formation.	Oral	presentation	at	AGSIP	Symposium,	University	of	Wisconsin	–	Milwaukee.		
Pullins,	S.E.,	Cullen,	P.K.,	Helmstetter,	F.J.	2017.	Contributions	of	the	retrosplenial	cortex	to	event-related	and	contextual	memory	formation.	Oral	presentation	at	UWM	Spring	Neuroscience	Symposium,	University	of	Wisconsin	–	Milwaukee.		
Pullins,	S.E.	April	2016.	Age-related	deficits	in	trace	fear	conditioning	and	activity	related	protein	degradation.	Oral	presentation	at	AGSIP	Symposium,	University	of	Wisconsin	–	Milwaukee.					
TEACHING	AND	OUTREACH:		
Association	for	the	Advancement	of	University	Women,	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	
Assistant	Teacher	|	August	2016	–	Present	
	
Molecular	Basis	of	Memory,	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	
President	|	August	2017	–	Present	
	
Guest	Lecture:	Psychopharmacology,	Introduction	to	Neuropsychology	-	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	|	February	2017		
Molecular	Basis	of	Memory,	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	
Vice	President	|	August	2016	–	August	2017	
	
		 49	
Teaching	Assistant,	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	Behavioral	Neuroscience	Laboratory	|	Spring,	2016	
	
Teaching	Assistant,	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	Behavioral	Neuroscience	Laboratory	|	Fall,	2015	
	
Teaching	Assistant,	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	Introduction	to	Physiological	Psychology	|	Spring,	2015		
Teaching	Assistant,	University	of	Wisconsin	–	Milwaukee,	Milwaukee,	Wisconsin	Administrative	Assistant	|	Fall,	2014	
	
Nu	Rho	Psi	Gamma	in	Ohio,	Miami	University,	Oxford,	Ohio	
President	|	November	2012	–	May	2014	
	
Talawanda-Miami	Science	Week,	Miami	University,	Oxford,	Ohio	
Assistant	Teacher	|	Spring	2013,	Spring	2014		
Distinguished	Undergraduate	Teaching	Fellowship,	Miami	University,	Oxford,	Ohio	Psychopharmacology	|	Spring	2014		
Distinguished	Undergraduate	Teaching	Fellowship,	Miami	University,	Oxford,	Ohio	Introduction	to	Biopsychology	|	Fall	2013		
Teaching	in	Neuroscience	Capstone,	Miami	University,	Oxford,	Ohio	Assistant	Teacher	|	Spring,	2013		
SKILLS/TECHNIQUES:		
Rodent	Behavior:	Pavlovian	context	fear	conditioning,	Pavlovian	cued	fear	conditioning,	fear	extinction,	maternal	separation,	restraint	stress,	open	field	analysis,	elevated	plus	maze	analysis,	forced	swim	testing,	chronic	variable	stress		
Biological:	fluorescent	in	situ	hybridization,	surgical	cannulation,	tissue	extraction	and	sectioning,	fluorescent	microscopy,	western	blotting,	optogenetics,	confocal	microscopy,	immunohistochemistry,	immunofluorescence,	retrograde	tract	tracing		
Software:	SPSS,	GraphPad	Prism,	Freescan	and	Freeze	Frame,	ImageJ,	GeneSys,	MedPC/MedAssociates		
